45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
161,622
Insurances with rates
51
CPT / HCPCS codes
0
Most expensive procedures (gross)
51905029-2247357
$414,026
30237-8900-06 - sipuleucel-T - Susp
Gross
$752,774
51905029-2247357
$180,666
30237-8900-06 - sipuleucel-T - Susp
Gross
$752,774
108329173-2255213
$311,025
71336-1001-01 - givosiran 189 mg/mL Soln
Gross
$565,500
108329173-2255213
$135,720
71336-1001-01 - givosiran 189 mg/mL Soln
Gross
$565,500
1279402-2255213
$271,805
00003-2328-22 - ipilimumab Soln
Gross
$494,190
1279402-2255213
$118,606
00003-2328-22 - ipilimumab Soln
Gross
$494,190
108087544-2247355
$237,202
67979-0002-01 - histrelin 50 mg Implan
Gross
$431,276
108087544-2247355
$103,506
67979-0002-01 - histrelin 50 mg Implan
Gross
$431,276
108963946-2247355
$228,708
69866-1025-01 - autologous cultured chondrocytes 0
Gross
$415,834
108963946-2247355
$99,800
69866-1025-01 - autologous cultured chondrocytes 0
Gross
$415,834
108963947-2247355
$228,708
69866-1030-05 - autologous cultured chondrocytes i
Gross
$415,834
108963947-2247355
$99,800
69866-1030-05 - autologous cultured chondrocytes i
Gross
$415,834
108978003-2247355
$228,708
69866-1030-08 - autologous cultured chondrocytes 1
Gross
$415,834
108978003-2247355
$99,800
69866-1030-08 - autologous cultured chondrocytes 1
Gross
$415,834
109228707-2247357
$227,694
00310-4535-30 - tremelimumab actl 20 mg/mL Soln
Gross
$413,990
109228707-2247357
$99,358
00310-4535-30 - tremelimumab actl 20 mg/mL Soln
Gross
$413,990
104437516-2255213
$222,673
75987-0080-10 - pegloticase 8 mg/mL Soln
Gross
$404,861
104437516-2255213
$97,167
75987-0080-10 - pegloticase 8 mg/mL Soln
Gross
$404,861
1286149-2255213
$222,673
54396-0801-01 - pegloticase Soln
Gross
$404,861
1286149-2255213
$97,167
54396-0801-01 - pegloticase Soln
Gross
$404,861
95367892-2255213
$222,673
60809-0801-01 - pegloticase 8 mg/mL Soln
Gross
$404,861
95367892-2255213
$97,167
60809-0801-01 - pegloticase 8 mg/mL Soln
Gross
$404,861
108107889-2255213
$203,667
72694-0954-01 - pegaspargase 3,750 IntlUnit(s) / 5
Gross
$370,304
108107889-2255213
$88,873
72694-0954-01 - pegaspargase 3,750 IntlUnit(s) / 5
Gross
$370,304
1282361-2255213
$203,667
57665-0002-02 - pegaspargase 3750. Soln
Gross
$370,304
1282361-2255213
$88,873
57665-0002-02 - pegaspargase 3750. Soln
Gross
$370,304
1282362-2255213
$203,667
54482-0301-01 - pegaspargase 3750. Soln
Gross
$370,304
1282362-2255213
$88,873
54482-0301-01 - pegaspargase 3750. Soln
Gross
$370,304
94990000-2255213
$196,987
57894-0061-03 - ustekinumab 90 mg/mL Soln
Gross
$358,159
94990000-2255213
$85,958
57894-0061-03 - ustekinumab 90 mg/mL Soln
Gross
$358,159
108326359-2255213
$187,264
25682-0028-01 - ravulizumab 100 mg/mL Soln
Gross
$340,479
108326359-2255213
$81,715
25682-0028-01 - ravulizumab 100 mg/mL Soln
Gross
$340,479
108290516-2247357
$180,731
72187-0401-01 - tagraxofusp 1000 mcg/mL Soln
Gross
$328,602
108290516-2247357
$78,864
72187-0401-01 - tagraxofusp 1000 mcg/mL Soln
Gross
$328,602
102623540-2114382
$169,733
CHRG - HEART ACQ FEE 263
Gross
$308,605
102623540-2114382
$74,065
CHRG - HEART ACQ FEE 263
Gross
$308,605
102623539-2114382
$159,121
CHRG - KIDNEY OS DON ACQFEE 266
Gross
$289,311
102623539-2114382
$69,435
CHRG - KIDNEY OS DON ACQFEE 266
Gross
$289,311
102623549-2114382
$159,121
CHRG - KIDNEY LIVDON ACQFEE 266
Gross
$289,311
102623549-2114382
$69,435
CHRG - KIDNEY LIVDON ACQFEE 266
Gross
$289,311
96694815-2255213
$157,002
50242-0150-01 - ocrelizumab 300 mg/10 mL Soln
Gross
$285,458
96694815-2255213
$68,510
50242-0150-01 - ocrelizumab 300 mg/10 mL Soln
Gross
$285,458
108290269-2247357
$153,763
79952-0110-01 - loncastuximab tesirine 10 mg Injec
Gross
$279,569
108290269-2247357
$67,097
79952-0110-01 - loncastuximab tesirine 10 mg Injec
Gross
$279,569
100133675-2114382
$148,053
4060018 OTH STER SUPP LVL 18[Omnicell Cath Lab]
Gross
$269,188
100133675-2114382
$64,605
4060018 OTH STER SUPP LVL 18[Omnicell Cath Lab]
Gross
$269,188
103179668-2114382
$148,053
4070018 OTH STER SUPP LVL 18[Omnicell EP Lab]
Gross
$269,188
103179668-2114382
$64,605
4070018 OTH STER SUPP LVL 18[Omnicell EP Lab]
Gross
$269,188
110842147-2114382
$148,053
KIT LVAS IMPL HRTMT 3 CIRCLTRY106524US[INLHCVOR]
Gross
$269,188
110842147-2114382
$64,605
KIT LVAS IMPL HRTMT 3 CIRCLTRY106524US[INLHCVOR]
Gross
$269,188
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 51905029-2247357 | 30237-8900-06 - sipuleucel-T - Susp | $752,774 | $414,026 | — | — | 8 |
| 51905029-2247357 | 30237-8900-06 - sipuleucel-T - Susp | $752,774 | $180,666 | — | — | 12 |
| 108329173-2255213 | 71336-1001-01 - givosiran 189 mg/mL Soln | $565,500 | $311,025 | — | — | 8 |
| 108329173-2255213 | 71336-1001-01 - givosiran 189 mg/mL Soln | $565,500 | $135,720 | — | — | 12 |
| 1279402-2255213 | 00003-2328-22 - ipilimumab Soln | $494,190 | $271,805 | — | — | 8 |
| 1279402-2255213 | 00003-2328-22 - ipilimumab Soln | $494,190 | $118,606 | — | — | 13 |
| 108087544-2247355 | 67979-0002-01 - histrelin 50 mg Implan | $431,276 | $237,202 | — | — | 8 |
| 108087544-2247355 | 67979-0002-01 - histrelin 50 mg Implan | $431,276 | $103,506 | — | — | 12 |
| 108963946-2247355 | 69866-1025-01 - autologous cultured chondrocytes 0 | $415,834 | $228,708 | — | — | 7 |
| 108963946-2247355 | 69866-1025-01 - autologous cultured chondrocytes 0 | $415,834 | $99,800 | — | — | 12 |
| 108963947-2247355 | 69866-1030-05 - autologous cultured chondrocytes i | $415,834 | $228,708 | — | — | 8 |
| 108963947-2247355 | 69866-1030-05 - autologous cultured chondrocytes i | $415,834 | $99,800 | — | — | 12 |
| 108978003-2247355 | 69866-1030-08 - autologous cultured chondrocytes 1 | $415,834 | $228,708 | — | — | 8 |
| 108978003-2247355 | 69866-1030-08 - autologous cultured chondrocytes 1 | $415,834 | $99,800 | — | — | 12 |
| 109228707-2247357 | 00310-4535-30 - tremelimumab actl 20 mg/mL Soln | $413,990 | $227,694 | — | — | 8 |
| 109228707-2247357 | 00310-4535-30 - tremelimumab actl 20 mg/mL Soln | $413,990 | $99,358 | — | — | 12 |
| 104437516-2255213 | 75987-0080-10 - pegloticase 8 mg/mL Soln | $404,861 | $222,673 | — | — | 7 |
| 104437516-2255213 | 75987-0080-10 - pegloticase 8 mg/mL Soln | $404,861 | $97,167 | — | — | 12 |
| 1286149-2255213 | 54396-0801-01 - pegloticase Soln | $404,861 | $222,673 | — | — | 8 |
| 1286149-2255213 | 54396-0801-01 - pegloticase Soln | $404,861 | $97,167 | — | — | 12 |
| 95367892-2255213 | 60809-0801-01 - pegloticase 8 mg/mL Soln | $404,861 | $222,673 | — | — | 8 |
| 95367892-2255213 | 60809-0801-01 - pegloticase 8 mg/mL Soln | $404,861 | $97,167 | — | — | 12 |
| 108107889-2255213 | 72694-0954-01 - pegaspargase 3,750 IntlUnit(s) / 5 | $370,304 | $203,667 | — | — | 7 |
| 108107889-2255213 | 72694-0954-01 - pegaspargase 3,750 IntlUnit(s) / 5 | $370,304 | $88,873 | — | — | 12 |
| 1282361-2255213 | 57665-0002-02 - pegaspargase 3750. Soln | $370,304 | $203,667 | — | — | 8 |
| 1282361-2255213 | 57665-0002-02 - pegaspargase 3750. Soln | $370,304 | $88,873 | — | — | 12 |
| 1282362-2255213 | 54482-0301-01 - pegaspargase 3750. Soln | $370,304 | $203,667 | — | — | 8 |
| 1282362-2255213 | 54482-0301-01 - pegaspargase 3750. Soln | $370,304 | $88,873 | — | — | 12 |
| 94990000-2255213 | 57894-0061-03 - ustekinumab 90 mg/mL Soln | $358,159 | $196,987 | — | — | 8 |
| 94990000-2255213 | 57894-0061-03 - ustekinumab 90 mg/mL Soln | $358,159 | $85,958 | — | — | 12 |
| 108326359-2255213 | 25682-0028-01 - ravulizumab 100 mg/mL Soln | $340,479 | $187,264 | — | — | 8 |
| 108326359-2255213 | 25682-0028-01 - ravulizumab 100 mg/mL Soln | $340,479 | $81,715 | — | — | 12 |
| 108290516-2247357 | 72187-0401-01 - tagraxofusp 1000 mcg/mL Soln | $328,602 | $180,731 | — | — | 8 |
| 108290516-2247357 | 72187-0401-01 - tagraxofusp 1000 mcg/mL Soln | $328,602 | $78,864 | — | — | 12 |
| 102623540-2114382 | CHRG - HEART ACQ FEE 263 | $308,605 | $169,733 | — | — | 8 |
| 102623540-2114382 | CHRG - HEART ACQ FEE 263 | $308,605 | $74,065 | — | — | 10 |
| 102623539-2114382 | CHRG - KIDNEY OS DON ACQFEE 266 | $289,311 | $159,121 | — | — | 8 |
| 102623539-2114382 | CHRG - KIDNEY OS DON ACQFEE 266 | $289,311 | $69,435 | — | — | 10 |
| 102623549-2114382 | CHRG - KIDNEY LIVDON ACQFEE 266 | $289,311 | $159,121 | — | — | 8 |
| 102623549-2114382 | CHRG - KIDNEY LIVDON ACQFEE 266 | $289,311 | $69,435 | — | — | 10 |
| 96694815-2255213 | 50242-0150-01 - ocrelizumab 300 mg/10 mL Soln | $285,458 | $157,002 | — | — | 8 |
| 96694815-2255213 | 50242-0150-01 - ocrelizumab 300 mg/10 mL Soln | $285,458 | $68,510 | — | — | 13 |
| 108290269-2247357 | 79952-0110-01 - loncastuximab tesirine 10 mg Injec | $279,569 | $153,763 | — | — | 8 |
| 108290269-2247357 | 79952-0110-01 - loncastuximab tesirine 10 mg Injec | $279,569 | $67,097 | — | — | 12 |
| 100133675-2114382 | 4060018 OTH STER SUPP LVL 18[Omnicell Cath Lab] | $269,188 | $148,053 | — | — | 8 |
| 100133675-2114382 | 4060018 OTH STER SUPP LVL 18[Omnicell Cath Lab] | $269,188 | $64,605 | — | — | 12 |
| 103179668-2114382 | 4070018 OTH STER SUPP LVL 18[Omnicell EP Lab] | $269,188 | $148,053 | — | — | 8 |
| 103179668-2114382 | 4070018 OTH STER SUPP LVL 18[Omnicell EP Lab] | $269,188 | $64,605 | — | — | 12 |
| 110842147-2114382 | KIT LVAS IMPL HRTMT 3 CIRCLTRY106524US[INLHCVOR] | $269,188 | $148,053 | — | — | 8 |
| 110842147-2114382 | KIT LVAS IMPL HRTMT 3 CIRCLTRY106524US[INLHCVOR] | $269,188 | $64,605 | — | — | 12 |
Showing top 50 of 161,622 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.